the Ministry of Labor, Health, and Solidarity in france announced the signing of a new framework agreement between the Economic Committee for Health Products (CEPS) and several organizations representing manufacturers, including Snitem, UFAT, Entreprises de la Nutrition Clinique, and AFIDEO. This agreement, finalized on July 2, 2024, pertains to the conventional policy for setting and revising the prices of products listed in the list of products and services (LPPR). The agreement is a significant step towards streamlining the pricing processes for medical devices in France and aims to create a more transparent and efficient system for both manufacturers and regulators.
The newly established framework agreement aims to govern the relationships between CEPS and the members of the signatory professional organizations, which include operators, manufacturers, and distributors. It seeks to provide economic actors with better visibility and facilitate tariff negotiations. By creating a structured approach to pricing and revisions, the agreement aims to streamline processes and ensure fairness in the market. The agreement is expected to provide clarity and stability, which are crucial for the planning and operation of businesses involved in the production and distribution of medical devices. Additionally, this framework is designed to encourage innovation and investment in the medical devices sector by providing a predictable regulatory environment.
Conventional Policy Monitoring Committee (CSPC)
A key feature of the agreement is the establishment of a Conventional Policy Monitoring Committee (CSPC). This committee is tasked with addressing any subject that contributes to the development of the conventional policy for products and services listed in the LPPR. The CSPC will convene at least twice a year, with the inaugural meeting scheduled for September 2024.
The committee’s role is crucial in ensuring that the framework remains responsive to the needs of the market and the stakeholders involved. The CSPC will act as a forum for dialogue and cooperation, allowing stakeholders to discuss and resolve issues related to the implementation of the agreement. This collaborative approach is expected to enhance the effectiveness of the policy and ensure that it remains aligned with the evolving needs of the healthcare sector.
Three-year agreement to provide stability and clarity
The framework agreement is set to be in effect for three years from the date of signing by the parties involved. This duration allows for sufficient time to implement the agreed-upon policies and to make necessary adjustments based on the outcomes of the CSPC meetings. By providing a stable and clear framework, the agreement is expected to foster a more predictable and efficient environment for pricing and revising medical devices included in the LPPR.
This period also allows for the collection and analysis of data to evaluate the impact of the new policies on the market. The insights gained during this period will be invaluable for future policy adjustments and improvements. The agreement is a testament to the commitment of all parties involved to improve the healthcare system and ensure that patients have access to high-quality medical devices.
Resource: Ministere Du Travail De La Sante Et Des Solidarites, July 11, 2024
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
